6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-23), Aytu BioPharma's 6-1 Month Momentum % is -3.18%.
The industry rank for Aytu BioPharma's 6-1 Month Momentum % or its related term are showing as below:
AYTU's 6-1 Month Momentum % is ranked worse than 73.24% of 1106
companies
in the Drug Manufacturers industry
Industry Median: 0.455
vs AYTU: -3.18
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Aytu BioPharma's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aytu BioPharma 6-1 Month Momentum % Distribution
For the Drug Manufacturers industry and Healthcare sector, Aytu BioPharma's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Aytu BioPharma's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Aytu BioPharma 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Aytu BioPharma's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Aytu BioPharma (Aytu BioPharma) Business Description
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AYTU has been successfully added to your